Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Vivani Medical, Inc. (VANI)

$1.28 -7.91% NASDAQ: VANI · 15-min delayed
  • ALAMEDA, California
  • Public · NASDAQ: VANI
  • 36 employees
$101.8MMarket cap
$4.0MRevenue · FY2016
-$26.6MNet income
36Employees
VANINASDAQ
2022IPO

About Vivani Medical, Inc.

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2016
$4.0M
Net income
-$26.6M
Total assets
$39.4M
Market cap
$101.8M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating expenses
$27.6M
Operating income
-$27.6M
Net income
-$26.6M
EPS (basic)
$-0.43
EPS (diluted)
$-0.43

Balance sheet

Total assets
$39.4M
Current assets
$17.9M
Total liabilities
$23.7M
Current liabilities
$6.6M
Shareholders’ equity
$15.7M

Cash flow

Operating cash flow
-$24.3M
Investing cash flow
-$1.2M
Financing cash flow
$23.3M
Net cash flow
-$2.2M

Statements via Polygon.io (SEC filings)

NASDAQ: VANI
$1.28 -7.91%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.94 $1.87

52-week range

Market cap
$101.8M
EPS (diluted)
$-0.43
Shares outstanding
79.5M
Open
Day range
Prev close
Volume
IPO date
Aug 31, 2022

Vivani Medical, Inc. (VANI) Stock Price

  • Reported a net loss of $26.6M in FY2016.
  • Trading 32% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

No reviews yet. Be the first to review Vivani Medical, Inc..

Write a review
Newsroom

News about Vivani Medical, Inc.

News & sentiment via Polygon.io

FAQ

Vivani Medical, Inc.: frequently asked questions

Is Vivani Medical, Inc. an American company?

Vivani Medical, Inc. is a US-based company headquartered in Alameda, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Vivani Medical, Inc. headquartered?

Vivani Medical, Inc. is headquartered in Alameda, California, United States.

Is Vivani Medical, Inc. publicly traded?

Yes — Vivani Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol VANI on the NASDAQ.

What does Vivani Medical, Inc. do?

Vivani Medical, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →